Clinical Trials Logo

Clinical Trial Summary

This clinical trial is a multi-center, double-blind, randomized, active controlled , parallel design, non-inferiority phase 4 study to evaluate the efficacy and safety of Entelon 150mg in 278 patients with chronic venous disease.


Clinical Trial Description

This study is to prove that Entelon tab. 150mg is non-inferior in clinical efficacy and safety compared to Venitol tab. for 8 weeks in patients suffering from chronic venous disease. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04882228
Study type Interventional
Source Hanlim Pharm. Co., Ltd.
Contact Nahyun Kang
Phone 82-2-3489-6298
Email nahyun.kang@hanlim.com
Status Recruiting
Phase Phase 4
Start date January 28, 2021
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT00766974 - Compression Aided Management of Edema in Patients With C3 Venous Disease Phase 4
Recruiting NCT05005052 - Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities Phase 3
Completed NCT04101201 - Clinical Trial to Assess the Efficacy of µSmin® Plus N/A
Not yet recruiting NCT04901845 - VEIN Health - CVD Prevalence and Characteristics
Completed NCT01801891 - Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers Phase 2
Not yet recruiting NCT06318988 - Outcomes of Different Treatment Options in Chronic Venous Disease
Completed NCT04574375 - Chronic VEnous dIsorders maNagement and Treatment effectivenesS evaluaTion in Chronic vEnous Disease, an International Program
Completed NCT04310280 - Effects of Local Insulin on Varicose Ulcers for Wound Healing Phase 3
Completed NCT03722836 - Evaluation of the Efficacy and Tolerability of Detralex in Patients With Chronic Venous Edema in Real Clinical Practice
Not yet recruiting NCT05612217 - Evaluation of the AIVARIX in Detecting Signs C 1-2 Classes of CVD
Completed NCT02137499 - Venous Insufficiency and Neuromuscular Stimulation N/A